Jeff S. Isenberg
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Nitric Oxide and Endothelin Effects, Phagocytosis and Immune Regulation, Apelin-related biomedical research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies(2009)292 cited
- → CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1(2006)280 cited
- → Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner(2005)269 cited
- → Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47(2010)223 cited
- → Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling(2007)197 cited
- → Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling(2009)179 cited
- → Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation(2010)147 cited
- → Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses(2008)146 cited
- → Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid Uptake(2007)134 cited
- → Thrombospondins: from structure to therapeutics(2008)131 cited